Soligenix Announces Recent Updates and First Quarter 2026 Financial Results

B PRINCETON, N.J., May 8, 2026 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing…
posteditor
posteditor
Articles: 21727